Glutamatergic agents for the treatment of cognitive impairments in patients with schizophrenia

被引：0
|
作者：
Buchanan, RW [1 ]
Gold, JM [1 ]
Bilder, R [1 ]
Green, M [1 ]
Javitt, DC [1 ]
Marder, SR [1 ]
Schooler, NR [1 ]
Heresco-Levy, U [1 ]
McMahon, RP [1 ]
Carpenter, WT [1 ]
机构：
[1] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA
来源：
SCHIZOPHRENIA BULLETIN | 2005年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：477 / 477
页数：1
相关论文
共 50 条
  • [21] Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect
    Weickert, TW
    Goldberg, TE
    Gold, JM
    Bigelow, LB
    Egan, MF
    Weinberger, DR
    ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (09) : 907 - 913
  • [22] Cognitive insight is correlated with cognitive impairments and contributes to medication adherence in schizophrenia patients
    Lui, Simon S. Y.
    Lam, Jessica P. Y.
    Lam, Joanna W. S.
    Chui, William W. H.
    Mui, Jolene H. C.
    Siu, Bonnie W. M.
    Cheng, K. M.
    Cheung, Eric F. C.
    Chan, Raymond C. K.
    ASIAN JOURNAL OF PSYCHIATRY, 2021, 60
  • [23] Glutamatergic drugs for schizophrenia treatment
    Gibert-Rahola, Juan
    Villena-Rodriguez, Abigail
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2014, 42 (05): : 234 - 241
  • [24] Glutamatergic agents for schizophrenia: current evidence and perspectives
    Zink, Mathias
    Correll, Christoph U.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (03) : 335 - 352
  • [25] Short term treatment responsiveness of cognitive impairments in first episode of schizophrenia
    Miclutia, I.
    Macrea, R.
    Popescu, C. A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S516 - S517
  • [26] Experimental Models of Cognitive Impairments in Schizophrenia
    Dorofeikova M.V.
    Kutcher E.O.
    Petrova N.N.
    Egorov A.Y.
    Neuroscience and Behavioral Physiology, 2021, 51 (6) : 765 - 773
  • [27] THE NEUROBIOLOGY OF COGNITIVE IMPAIRMENTS IN THE PRODROME TO SCHIZOPHRENIA
    Howes, Oliver D.
    Fusar-Poli, P.
    Allen, P.
    Egerton, A.
    Chaddock, C.
    McGuire, P.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 124 - 125
  • [28] Glutamatergic augmentation strategies for cognitive impairment in schizophrenia
    Goff, DC
    Bagnell, AL
    Perlis, RH
    PSYCHIATRIC ANNALS, 1999, 29 (11) : 649 - 654
  • [29] Probing the cognitive, clinical, and functional impairments of schizophrenia patients with mismatch negativity
    Light, GA
    Meyer-Gomes, K
    Sprock, J
    Braff, DL
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 111S - 111S
  • [30] Cognitive and functional impairments in elderly patients with schizophrenia: A review of the recent literature
    Harvey, PD
    HARVARD REVIEW OF PSYCHIATRY, 2001, 9 (02) : 59 - 68
12345